Journal Guide

Diabetes Technology & Therapeutics is the only peer-reviewed journal which provides healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of the latest technologies and therapeutics in the field. Each issue highlights new pharmacological and device developments to optimize patient care. The Journal fosters the development and use of new and emerging technologies to be applied to diabetes, including: Alternate insulin delivery methods Continuous glucose monitoring Artificial pancreas Computerized case management/telemedicine Detection and prevention of long-term micro- and macrovascular complicationsThe Journal publishes recent developments in pharmacologic therapy and device development with original papers, accompanied by analysis commentaries, on the performance of brand-name products.

Diabetes, Obesity & Metabolism is primarily a journal of clinical and experimental pharmacology and therapeutics covering the interrelated areas of diabetes, obesity and metabolism. The journal prioritises high-quality original research that reports on the effects of new or existing therapies, including dietary, exercise and lifestyle (non-pharmacological) interventions, in any aspect of metabolic and endocrine disease, either in humans or animal and cellular systems. 'Metabolism' may relate to lipids, bone and drug metabolism, or broader aspects of endocrine dysfunction. Preclinical pharmacology, pharmacokinetic studies, meta-analyses and those addressing drug safety and tolerability are also highly suitable for publication in this journal. Original research may be published as a main paper or as a research letter.

Diabetes/Metabolism Research and Reviews is an indispensable resource for clinicians and researchers working in the fields of diabetes, endocrinology, metabolism and obesity. Our reviews section provides the latest updates on clinical and basic scientific advances in key areas of diabetes, obesity and metabolism, important historical overviews, discussion of controversial issues and opinions from prominent researchers and clinicians. Original articles describing clinical studies, translational and basic research related to diabetes, obesity, metabolism, or closely related metabolic disorders are welcome, as are articles concerned with treatment and management issues related to patient care.Please note that Diabetes/Metabolism Research and Reviews is an online-only journal.Benefits for our authors:* No charges for colour figures* Accepted article PDFs are published within days of acceptance* Faster issue publication times for full final articles* Better integration of online supporting information for articlesDiabetes/Metabolism Research and Reviews publishes supplements. If you are interested in publishing a supplement, please visit our Contact page and select your region in the Advertising and Corporate Sales section.

Diabetic Medicine, one of the leading clinical diabetes journals in the world, publishes comprehensive reviews and original articles on clinical research and practice in diabetes. Issues also regularly include case reports, editorials, comment, news and correspondence. All material is peer-reviewed as the journal seeks to provide a forum for the exchange of information between clinicians and researchers worldwide and all health professionals responsible for the care of people with diabetes.

Diagnostics (ISSN 2075-4418) is an international scholarly open access journal on medical diagnostics. It publishes original research articles, reviews, communications and short notes on the research and development of medical diagnostics. There is no restriction on the length of the papers. Our aim is to encourage scientists to publish their experimental and theoretical research in as much detail as possible. Full experimental and/or methodological details must be provided for research articles.

Differentiation is a multidisciplinary journal dealing with topics relating to cell differentiation, development, cellular structure and function, and cancer. Differentiation of eukaryotes at the molecular level and the use of transgenic and targeted mutagenesis approaches to problems of differentiation are of particular interest to the journal.The journal will publish full-length articles containing original work in any of these areas. We will also publish reviews and commentaries on topics of current interest. The principal subject areas the journal covers are: • embryonic patterning and organogenesis• mechanisms of cell lineage commitment• tissue homeostasis• establishment of cellular polarity• stem cell differentiation• cell reprogramming mechanisms• stability of the differentiated state• cell and tissue interactions in vivo and in vitro• signal transduction pathways in development and differentiation• carcinogenesis and cancer• mechanisms involved in cell growth and division especially relating to cancer• differentiation in regeneration and ageing

In print since 1934, DDS covers a wide scope of basic and clinical aspects of gastroenterology, hepatology, outcomes research, and healthcare delivery all from prominent academicians and practitioners.

• Commentaries written by leading experts.
• Global and highly regarded editorial board composed of top scholars in the field.
• Special sections include Fellows and Young GIs, Current Clinical Controversies, and Mentored Reviews.
• Efficient peer review by knowledgeable authorities in the field.
• Fast publication and cost-free printing (including color figures).

Digital Discovery welcomes both experimental and computational work on all topics related to the acceleration of discovery such as screening, robotics, databases and advanced data analytics, broadly defined, but anchored in chemistry. The journal welcomes Artificial intelligence and data science methodologies for chemical, materials science, biochemical, biomedical or biophysical sciences including Computer-assisted retrosynthesis, Generative models for scientific design, Machine learning classification and regression models, Modern molecular, materials, and biological representations, Methods for Bayesian optimization and design of experiments, Advances and applications of interpretable models, Image recognition, Natural language processing, Literature mining tools, Advanced data workflows, Advances in robotics for science, Experimental control software, Databases, New robotic setups, New automated sensors, Novel synthetic methodologies and workflows, High-throughput computational science, Directed or accelerated evolution, DNA Encoded Library Technology, Cryptochemistry, and Blockchain-enabled science.

The journal publishes original research findings (and reviews solicited by the Editor) on the subject of the identification of markers associated with the disease processes whether or not they are an integral part of the pathological lesion. The disease markers may be a genetic host factor predisposing to the disease or the occurrence of cell-surface markers, enzymes or other components, either in altered forms, abnormal concentrations or with abnormal tissue distribution. This journal is designed to provide a forum for publications dealing with original observations in this developing field on any aspect of the general topic including: * Identification of new genetic or non-genetic markers (e.g., cell-surface antigens, serum proteins, intra- and extra-cellular enzymes, cytogenic markers and DNA-sequences) * Population studies of new and existing markers, designed to elucidate information on their normal distribution as well as that in disease states * Amplification of knowledge about existing markers * Family studies of markers in disease * New techniques for identification and/or isolation of important marker molecules * Use of monoclonal antibodies for the definition of molecular structures associated with disease markers * Identification of disease-associated abnormalities in DNA using recombinant DNA techniques, gene-cloning and DNA restriction enzyme fragment polymorphisms * Identification of markers identifying malignantly transformed neoplastic cells.

Disease Models & Mechanisms (DMM) is an Open Access biomedical research journal focusing on the use of model systems to better understand, diagnose and treat human disease. The primary aim of DMM is to promote human health by inspiring collaboration between basic and clinical researchers in translational science. The journal is committed to presenting rigorously peer-reviewed research that has significant translational impact. The interdisciplinary nature of DMM means that a diverse range of diseases, approaches and models fall within its broad scope. DMM is guided by an international team of expert research-active Editors, led by Editor-in-Chief Elizabeth Patton and Deputy Editor-in-Chief Elaine Mardis, and supported by an outstanding Editorial Advisory Board.

Doklady Biochemistry and Biophysics presents English translations of current Russian research from the biochemistry and biophysics sections of the Doklady akademii nauk (Proceedings of the Russian Academy of Sciences). The Proceedings appear 36 times per year; articles on biochemistry and biophysics are collected, translated, and published in 6 issues per year. Doklady Biochemistry and Biophysics publishes the most significant new research in biochemistry and biophysics being done in Russia today, thus ensuring its scientific priority. Since 2001, the journals Doklady Biochemistry and Doklady Biophysics have been combined.

Doklady Biological Sciences is a journal containing English translations of current Russian research in molecular biology, cell biology, microbiology, immunology, physiology, general biology and botanics, published in the corresponding sections of the Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences). The Proceedings appear 36 times a year, articles from the selected biological sections are collected, translated, and published in 6 issues a year. Doklady Biological Sciences publishes the most significant new research in the biological sciences being done in Russia today, thus ensuring its scientific priority.The Editorial Board of Doklady Akademii Nauk (Proceedings of the Russian Academy of Sciences) accepts new articles in the Russian language, formatted in accordance with the Rules for Authors. The article must be presented for publication by acting Russian or foreign members of the Russian Academy of Sciences.

Domestic Animal Endocrinology publishes scientific papers dealing with the study of the endocrine physiology of domestic animal species. Those manuscripts utilizing other species as models for clinical or production problems associated with domestic animals are also welcome.Topics covered include:Classical and reproductive endocrinologyClinical and applied endocrinologyRegulation of hormone secretionHormone actionMolecular biologyCytokinesGrowth factorsBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

The Drug Discovery Today reviews collection provides a resource of review content aligning the key output of human molecular medicine with the specific requirements of the drug discovery process. It is designed to systematically cover the essential elements of molecular medicine and drug discovery, in a manner that has relevance to those actually working on the discovery and development of new drugs. This collection will evolve to create a highly structured database and will act as a one-stop-shop for high quality content.Other titles in this series include:Drug Discovery Today: Disease ModelsDrug Discovery Today: Therapeutic StrategiesDrug Discovery Today: TechnologiesDrug Discovery Today: Disease Mechanisms covers the analysis of the molecules and pathways that fail or are subverted during the aetiology and pathogenesis of human disease. It focuses on what is actually known or strongly predicted about the human disease process.There will be 4 issues each year. The Drug Discovery Today reviews collection is only available online.Ethics in Publishing: General StatementThe Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict. For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest.

The Drug Discovery Today reviews collection provides a resource of review content aligning the key output of human molecular medicine with the specific requirements of the drug discovery process. It is designed to systematically cover the essential elements of molecular medicine and drug discovery, in a manner that has relevance to those actually working on the discovery and development of new drugs. This collection will evolve to create a highly structured database and will act as a one-stop-shop for high quality content.Drug Discovery Today: Disease Models discusses the non-human experimental models through which inference is drawn regarding the molecular aetiology and pathogenesis of human disease. It provides critical analysis and evaluation of which models can genuinely inform the research community about the direct process of human disease, those which may have value in basic toxicology, and those which are simply designed for effective expression and raw characterisation.Other titles in this series include:Drug Discovery Today: Disease MechanismsDrug Discovery Today: Therapeutic StrategiesDrug Discovery Today: TechnologiesThere will be four issues each year.The Drug Discovery Today reviews collection is only available online.Ethics in Publishing: General StatementThe Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict.For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest

The Drug Discovery Today reviews collection provides a resource of review content aligning the key output of human molecular medicine with the specific requirements of the drug discovery process. It is designed to systematically cover the essential elements of molecular medicine and drug discovery, in a manner that has relevance to those actually working on the discovery and development of new drugs. This collection will evolve to create a highly structured database and will act as a one-stop-shop for high quality content.

The Drug Discovery Today reviews collection provides a resource of review content aligning the key output of human molecular medicine with the specific requirements of the drug discovery process. It is designed to systematically cover the essential elements of molecular medicine and drug discovery, in a manner that has relevance to those actually working on the discovery and development of new drugs.This collection will evolve to create a highly structured database and will act as a one-stop-shop for high quality content.What are the biotechnical challenges in ensuring drug action, especially with regard to biopharmaceuticals? Drug Discovery Today: Therapeutic Strategies discusses the varied strategies used, including stem-cell therapy, vaccination, gene therapy, tissue modelling, tissue and non-tissue implants and many others.Other titles in this series include:Drug Discovery Today: Disease MechanismsDrug Discovery Today: Disease ModelsDrug Discovery Today: TechnologiesThere will be four issues each year. The Drug Discovery Today reviews collection is only available online.Ethics in Publishing: General StatementThe Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the Journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this Journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the Journal is the safest course. All submissions to the Journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The Journal may use such information as a basis for editorial decisions and may publish such disclosures if they are believed to be important to readers in judging the manuscript. A decision may be made by the Journal not to publish on the basis of the declared conflict. For more information, please refer to: http://www.elsevier.com/wps/find/authorshome.authors/conflictsofinterest.